Clin2
NCT07177235Possibly a fitNot yet recruiting

Ketamine for hard-to-stop seizures

Refractory Status Epilepticus

Treatments studied

Part of Brain & nervous system clinical trials.

This trial tests if ketamine can help stop seizures that haven't responded to standard medicines. It is for adults whose seizures continue after two or more emergency treatments.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
50 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • Must be 18 years or older
  • Seizures must continue after trying two standard treatments (like Ativan, Dilantin, or Keppra)
  • Seizures must not be caused by a mental health condition or be limited to one body part
  • Seizures must last less than 24 hours before starting the trial
  • You cannot be pregnant or in prison

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05851391Recruiting· Phase 2
Test drug treatment to stop hard-to-control seizures after cardiac arrest

This Phase 2 trial tests a medication strategy to stop “refractory status epilepticus,” a severe seizure condition that can happen after a cardiac arrest. It may help by reducing ongoing seizure activity after return of circulation in the ICU.

San Francisco, California
NCT05019885Recruiting· Phase 2
IV ketamine for hard-to-treat epilepsy in adults

This Phase 2 study tests whether a low dose of IV ketamine can reduce seizures in adults with drug-resistant epilepsy. It may help people whose seizures continue despite trying at least two appropriate seizure medicines.

New York, New York
NCT06788249Recruiting· Early Phase 1
Ketamine for treatment-resistant depression brain study

This trial tests whether a single dose of ketamine can quickly improve depression by studying brain chemical changes using MRI. It's for people with treatment-resistant depression who haven't used ketamine before.

Philadelphia, Pennsylvania
NCT03223220Not yet recruiting· Phase 2/Phase 3
Ketamine for stroke patients within 24 hours

This trial studies whether ketamine given soon after an ischemic stroke (blocked blood flow) can reduce early brain injury. It may help some people by limiting harmful brain reactions after stroke.

Wynnewood, Pennsylvania
NCT06907173Recruiting· Phase 3
Ketamine for ongoing seizures in the ER

This trial tests if adding ketamine to standard care can stop seizures that continue after a first treatment. It is for people having a convulsive seizure lasting more than 5 minutes and who are still seizing in the emergency room.

Tucson, Arizona
NCT07095842Recruiting· Phase 2/Phase 3
Early ketamine for kids with seizure emergencies

This trial tests if giving ketamine early, before reaching the hospital, can stop prolonged seizures in children with epilepsy. It is for kids who have had at least one seizure emergency in the past year.

Sohag

Hear when a new Refractory Status Epilepticus trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.